Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study-Reference-Cited by-同舟云学术

Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study

Published:2016-05-11 Issue:5 Volume:11 Page:e0155242
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Schuster Cornelia,Akslen Lars A.,Straume Oddbjørn

Funder

Norges Forskningsråd

Helse Vest

Kreftforeningen

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Worldwide increasing incidences of cutaneous malignant melanoma;DE Godar;J Skin Cancer,2011

2. Cancer treatment and survivorship statistics, 2012;R Siegel;CA Cancer J Clin,2012

3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;PB Chapman;N Engl J Med,2011

4. CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients;PA Ott;Clin Cancer Res,2013

5. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation;R Nazarian;Nature,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives;Life Sciences;2024-05

2. β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma;Cancer Medicine;2023-08-08

3. Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies;Cancers;2023-06-02

4. Tissue-Based Biomarkers of Tumor-Vascular Interactions;Biomarkers of the Tumor Microenvironment;2022

5. HSP90 inhibitor modulates HMGA1 and HMGB2 expression along with cell viability via NF-KB signaling pathways in melanoma in-vitro;Gene Reports;2021-09